Diabetes Flashcards

(52 cards)

1
Q

pathopys. of T2DM

A
  • a progressive disorder of insulin resistance within the body, leading to eventual deterioratino of the B cells in the pancreas and increased blood glucose & impaired hepatic production of glucose

Early Phase: an insulin resistance pattern occurs (a result of metabolic syndrome)
- pancreas initially HYPERSEcretes the insulin (thinking i need to make more to get it into the cells)
- but even with high levels of insulin, the cells (in muscle, fat and liver) stop responding to insulin and they wont take up any glucose (or a very small level)
- overtime though, the cells wear out and cant make insulin anywhere

the FIRST sign of insuin resistance and T2DM is the LOSS of the post-prandial insulin spike after meals; the body is unable to do that = post-pradial hyperglycemia

Later on: the body is unable to produce insulin at all: leading to a state of fasting hyperglycemia as there is no insulin response at all to lower blood glucose

Additionally…
- loss of insulin means theres not regulation of glucagon release: thus glucagon released: breaks down stores glucose & results in even more hyperglycemia
- lack of insulin also triggers the liver cells to think they need to form more glucose: through gluconeogensis which results in a resting state of hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the Dawn Phenomenon
- patho & significance

A
  • the AM hyperglycemic spike which results due to the NATURAL secretion of counter-regulatory hormones at 3am = trigger a raised glucose in the serum
  • this phenomenon is common in those with DM, and sleep apnea
  • see blood sugars as high as 150-200s

Counter-regulatory hormones
- cortisol
- glucagon
- growth hormone
- catecholamines (noreip and ei)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Somogyi Effect

A
  • AM reactive hyperglycemia as a result of an overnight hyPOglycemic event
  • sOmOgyi = hypOglycemia Overnight

example of the effect
- pt takes their insulin at bedtime, develops low blood sugar overnight, so the counter regulatory hormones trigger an increase in blood sugar resulting in hyperglycemia in the morning

screen by asking bed partner; are thye sweaty, shakey, pale and signs of hypoglycemia overnigh that you noticed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Etiology of T2DM
- individual factors
- risk factors

A

Etiology = multifactoral
- Genetics: plays a HUGE role and links of family history make someone significantly more likely to develop it
- environmental factors
- sedintary lifestle, eating habits and body habitus (apple shaped)

Risk Factors
- OBESITY and central adiposity
- family history
- CVD
- sedintary lifestyle!!!
- latino/hispanic, asian, islander (underrepresented pop.) are more at risk
- signs of insulin resistance (impaired fasting glucose)
- HTN
- dyslipidemia
- history of gestational diabetes
- history of large baby devleiry ( > 9lbs)
- PCOS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications which may induce or increase the risk of T2DM

Medical Conditions which may cause T2DM

A
  • atypical antipsychotics!!!: the risperidone, etc. (not the haldol and first-gens)
  • chronic oral steroid use (prednisone) for immune conditions
  • OCPs
  • statin use ?

Medical Conditions
- OSA: increased cortisol production = hyperglycemia
- cushings disease: increased cortisol
- acromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Patho of Type 1 DM

A

an immunologic destruction (auto-immune) of the beta cells in the pancreas leading to complete lack of insulin release

  • lack of insulin release leads to a lack of glucoses abiity to enter ANY cells: making the cells resort to other energy production (ketoacidosis occurs due to the byproducts) and DKA can occur
  • hyperglycemia will occur and death withinout the introduction of exogenous insulin
  • some thought of environmental triggers (viruses, toxins, etc.) can trigger the occurance of the destruction to occur
  • genetic link: auto-immune mutation then the insinulating event happnes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk Factors for T1DM

A
  • viral infection: coxackie, mumps, rubella
  • family history of T1DM (not as strong as T2DM)
  • family history or personal hsitory of other autoimmune disease
  • scandinavian or northern european decent
  • early diagnosis: like age 4-6 or 10-14 most commonly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Key Aspects of a pt. which may clue you into thinking they have Type 1 DM

A
  • auto-immune personal hx or family hx.
    • GAD65, low peptide -C levels
  • younger age dx. (before 18)
  • fair skin, northern european
  • small body habitus
  • failed oral diabetic medications
  • requiring basal and bolous insulin
  • presentation of DKA at first signs can be extremely common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Key Aspects of pt. presenation which may clue you into thinking they have T2DM

A
  • obese body habitus
  • family hx. of T2DM
  • metabolic syndrome (HTN, high lipids, obese, central adiposity)
  • meds causing insulin resisatnce
  • older age (40s-60s)
  • PE significant for: acanthosis nigricans or skin tags (acrocordons)
  • presenation of HHS/HHNK:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is LADA
- etiology
- presentation
- diagnosis
- treatment

A

LADA: latent autoimmune diabetes of adulthood

Etiolgy: an insidious onset of type 1 DM where the beta cells are slowly, over time destoryed leading to a much later presentation of full blown T1DM

Presentation
- over 18: slender body habitus with no signs or fam hx. of T2DM

Diagnosis
- pts have + GAD65/anti-islet cells AB but with normal C=peptide (because they are making some insulin….. for now)

Treatment
- the pts. will slowly over time need to become insulin dependent
- pts. with varying BMI will need insulin at different times in life
- if the BP spike is out of proportion to the baseline of BS for the pt. start them on insulin!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other Classifications of DM

A

steroid induced
- this is a diagnosis for those on CHRONIC or LONGTERM steroid use which results in hyperglycemia
- this is NOT a short corse of steroids spiking the glucose

MODY (maturity onset diabetes of youth)
- eary DM in a genetic atuo. dominat pattern
- non-obese white with no antibodies and not needing insulin

Gestational DM
- from pregnancy and makes mom more likely to develop T2DM afterwards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Pre-Diabetes

A

the KEY point for intervention in pt. education to prevent DM!!!! if you can at this point

A1c 5.8-6.4%
Or fasting glucose 101-125

a point of insulin resistance development priot to overt dx. of DM

Treatment
- pt. education
- lifestyle modification!!!! lost weight by 5-10% is best
- change diet to mediterranean
- 150 mins. of CV intense exercise weekly
- check BS 1x daily

for those with extremely high risk or high A1c can be acceptable to begin metformin at this stage

Treatment
- rerduce risk of other diseae states (CVD risk) and llifestly changes
- HTN control: ACE/ARB
- HLD: statin thearpy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diabetes: Pt. Presentation

A

most times: your pt. will come in asymptomatic: thus you MUST be on the look out

the 3 ps: polyuria, polydypisa, polyphagia

  • fatigue
  • anorexia
  • mental status change (in HHS with hyperglycemia)
  • weight loss: in VERY uncontrolled : peeing out the sugar, no cells getting any glucose leads to loss
  • vision changes (thickened lens or microvas. comp)
  • paresthesias of the feet and extremities
  • recurrent UTo ro mycotic infection: increase glucose in urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is DM diagnosed
- labs

how is pre-diabetes diagnosed

specifics on the A1C

A

one of the following is significant enough for a diagnosis of DM

  • signs of DM (3 ps, weight loss) + random plasma glucose level of > 200
  • a fasting glucose > or equal to 126 on 2 checks
  • oral glucose test > 200 = not commonly done
  • A1C = or > 6.5% = (most commonyl done becuase no need to fast)

Pre-Diabetes
- an A1C 5.8-6.4%
- a fasting glucose ** 101-125**

A1C specifics
- preferred screening method & good for long term monitoring of DM
- measures 3 month glucose contorl: by measuring teh glycosylation of the red blood cells via an irreversible bond of the glucose and protein on the RBC: proportional to the glucose lvel (aka how much glucose the rbc has been swimming in)

  • an A1c level can be impacting by severe anemia, hemoglobopathies and hemoylic anemia: in this cause a serum frutosamine can be used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diabetic Monitoring of sugar

monitoring for T1DM
monitoring for T2DM

A

a hallmark of DM management: glucose must be monitored
- a blood glucose level must be checked regardless of type of DM and regardless of teh A1c level: blood glucose gives exact NOW measurement of glucose in the serum

Type 1 DM
- AM check, before meals & at bedtime (4 times a day)

Type 2 DM
- AM check, before meals, and before bed if sugars not controlled

GM (gestaional)
- AM check, before meals, 2 hours after meals, at bedtime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DM Complications

A

major complications are revolved around macrovascular and microvascular issues

Macrovascular: secondary to large vessel disease
- CAD
- stroke
- PAD

Microvascular: smaller vessel: but still significant lifestyle implications
- retinopathy
- nephropathy
- neuropathy

other complications (secondary to those above usually)
- foot and leg ulcers (ischemic and neurologic issues)
- skin issues (acnthosis nigricans, necrobiosis, skin tags)
- MSK abnormalities
- infections
- hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Macrovascular Complications
- what disease and why
- how do you approach treatment

A

CAD/CVD = leading to an MI event
atherosclerosis of the ICA: stroke
PAD of LE: leading to gangrene and ischemic ulcers

Patho: not entirely known but…
- LDL cholesterol is fragmented: possibly due to glucose: making it easier for it to oxidize and become a plaque & CVD risk increaed dramatically

Treatment Approach
- treat those with DM just like someone who had a previous MI (same CVD risk)
- use ASCVD risk score calculator: but DM pt. will need to be treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment of CVD risk in those with DM

A

smoking cessation: a MUST

  • prevent CAD/CVD SECONDARY (already had one) with low dose asprin daily
  • prevent/treat HTN: ACE/ARB treatment
    this helps with albuminuria too and kidney protection
    goal BP: < 130/80
  • Lipid management: treating pt. regardless of cholesterol level
    advise with lifestyle management
    age 40-75 without ASCVD risk: moderate intensity statin
    age 40-75 with ASCVD risk: high intensity statin so rousuvisatin or atorvostatin can be high dose

(age less than 40 requires a convo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Microvasculariation Complications of DM

Retinopathy

screening, types & treatment

A

Screening
T1DM: 5 years after diagnosis or those with visual changes
T2DM: at time of diagnosis

Types of retinopathy
1. non- proliferative = early stage of the disease, microanyuresums, dot hemorrhages, exudates & retinal edema
2. proliferative = new capillary gorwth, fiberous tissue creation, retinal hypoxia leading cause of blindness & risk of vitreous hemorrhae and retial detachment high

Treatment
- laser photocoag.
- VEGF injection
- control the DM
- stok smoking
- treat the HTN
- yearly eye checks at minimum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Microvascular Complication of DM
Nephropathy

patho, labs, screening, treatment

A

leading cause of ESRD is DM

Patho
- hyperglycemia leads to hyperfilteration in the kidneys (because there gets to a point where the body can no longer reuptake the glucose: tmax thus the glucose begins to spill into the urine; where glucose goes (solute) the fluid will follow & creates hyper filteration of other substances out with it
- additionally: the glucose deposits within the basement membrane of the glomeruleus and creates a thickened membrane –> leads to damage to the podocytes & eventuall proteinuria results

Labs
- microalbuminuria is the first sign of nephropathy = leading to CKD
- microalbuminuria: 30-300
- macroalbuminuria: > 300

Screening
yearly urine studies for albumin

Treatment
- glycemic control
- HTN control
- ACE/ARB

because the ACEII works at the efferent arteriole: blocking the action of ACEII (through ACE) which was trying to increase filteration secondary to the hyperglucose but spilling protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Microvascular Complications of DM
neuropathy

patho, symptoms/signs, testing and treatmetn

A

peripheral and autonmoic neuropathy common in DM

Patho
- seondary to glycosylation of the neurons and therefore porr depolarization and neuronal death

Diabetic Neuropathy = hands, feet/legs
- stocking/golve beginning as sensory impairement then dullness to vibrations & temperature; eventually can result as biomechainal changes in the feet/legs (change in gait)
- charcot arthropathy = high foot pressure and repetitive stress results in biomecanical changes in the feet

isolated peripheral neuropathy = single nerve issues
- commonly CN 3/4/6 results in EOM weakness and diplopia
- diabetic amyotrophy: quad wasting due to weakness

Tests
- can do tuning fork vibrations to test for senstaion
- can do monofilament testing

Treatment: (treat the DM and manage)
peripheral neuropathy: orthotics in the shoes; should see vascular/podiatry yearly at dx. of t2 and 5yrs. after t1
- control the DM
- pain = cymbalta, gabapentein

Isolate Neuropathy
- CN palsy can resolve on its own in 6-12 weeks
- amyotrophy also resolves with DM control and pain meds after 6-18 months

Autonomic = gastropareieis, ED & diabetic diarrhea

22
Q

DM Complications
Hypoglycemia

defined, causes & physiologic response

A

most common complication of DM pts. who are on treatment ( sulfonaureas & glinides)

defined as = glucose < 70 (normal glucose 70-100)

Causes
- treatment/medications
- poor PO intake (not eating enough to balance)
- deaying meals after taking their insulin
- excessive exercsie wihtout proper adjustment of the glucose
- those with CKD/cirrhosis: improper ability to clear the medications they’re on (stick around longer and thus drop sugars even lower)

Physiologic Response
- when the glucose level in the blood falls below 70: bodily triggers try to increase the level
- glucagon: the first response to low suga: stimulated and tries to breakdown glucose stores
- Epi and Norepi (catecholamines) are realease too help : this is what gives you the shakey,sweaty, unwell feeling
- GH, cotrsiol and counterreg. hormones kick in

23
Q

Complications of DM
Hypoglycemia

symptoms/signs & treatment

A

Signs/Symptoms

minor hypoglycemia
- tachycardia, palpations, sweating, tremors, parasymp. nausea

Major hypoglycemia
- neuroglycopenia: confusion, bizzare behavior, coma
severe < 30 glucose = seizures

beta-blockers are a key medication which can BLOCK an individuals awareness of these hypoglycemic events

Long Term T1DM can result in hypoglycemic unawareness
- with long term DM1– there is not only a lack of insulin production but an overtime reduction in the glucagon response to increase sugars at times of low sugar
- poor awareness of the hypoglycemia is a result of the poor autonomic function that happens in diabetics
- repeated events of hypoglycemia make the phenomenon more likely to occur again

Treament
- always AVOID hypoglycemic events (increases, pt. risk of CVD and dementia) aggreesive treatment can precipitate this

Acute hypoglycemia with Unconscious pt.
- IV 1 amp D50
- if at home: rub honey,syrup in buccal mucosa

Acute hypoglycemia with conscious pt.
- rule of 15: give 15 g of carbohydrates than wait 15mins
- apple/orange jucie, glucose packets, sugar, etc.

24
Q

Skin Manifestations of DM

A
  1. acanthosis nigricans: deep, dark, purple, veltly like striae which exisit on the neck, armpits, etc. and are indications of insulin resistance
  2. acrochorons: skin tags = insulin resistance
  3. necrobiosis lipodica diabeticorum = shiny, ucler like appearance on teh antrior tibis which reslts from DM - removal but recurrance
25
Goals of Treatment for T1DM what is used names
**insulin dependent individuals: because they dont produce any on their own!!** - need Basal (consistent throughout the day) and Prandial (post-meals) insulin Basal Insulin: Lantus/Levemir, NPH (BID) Prandial Insulin: Humalog, Novolag, apidra can use insulin pumps with rapid acting insuling given over a 24 hour infusion **DO NOT USE PRE_MIXED INSULIN!!!**
26
Outline of Treatment for T2DM
**oral meds are given first before transition to the need for subq or injectables** hallmark of treatment is lifestyle changes - weight loss - avoid white carbs & adopt meditteranean diet - calorie restriction: 3 meals 3 snacks use of oral meds is prefered before going to insulin due to the additional benefits of CVD protection and renal protection
27
T2DM Meds Biguanides
**Metformin** (FIRST LINE TREATMENT) aka everyone should be on this unless they have a CI MOA: reduces gluconeogenesis in the liver and other tissues: through AMPK and mGPD & increases insulin mediated glucose uptake in the peripheral tissue Side Effects - **weight loss** (acting on a decrease in appetite) - GI symptoms (diarrhea, nasuea, **mild B12 risk**) Contraindicated - those in severe hepatic and renal failure (GFR < 50 & cr > 1.5 (CKD 3) & cirrhosis of liver, alcoholics) for risk of lactate acidosis able to reduce A1c : 1.5% (works to affect basal blood sugar levels)
28
T2DM medication sulfonylureas
**rarely used anymore** Names - glimepiride, glipizide, glyburide MOA: bind to the sufonylurea receptor complex at the beta cells to **increase the insulin release from beta cells** Side Effects - **weight gain: why we dont use** - **risk of hypoglycemia: why we dont use** CI - hepatic and renal failure, hypoglycemia often and poor PO intake A1C: reduction 1-5-2% **can progress to B cell failure totally: so not a great drug** helps to reduce basal BS
29
T2DM Medication Meglitinides "Glinides"
Glinides Names - repaglinide - nateglinide MOA: stimulates beta cell prodction of insulin **most often working on pradial spikes** Side Effects - less risk of hypoglycemia (but still a risk) - weight gain CI - CKD, hypoglyceia, liver disease and poor PO intake **dosed with meals to help with the pradial spikes & preferred use of these over the sulfonyureas**
30
T2DM Medication Thiazolidinediones (TZDs)
Names - piglitazone MOA: work on PPAR in the adipose tissue to be more receptive to insulin: actiavted HDl and decrease triglycerides Side Effects - weight gain - **EDEMA** - can increa fx. and BMD CI - cannot use in stage 3-4 HF, or bladder cancer or in smokers **too high or risk of bladder cancer and edema and not used**
31
T2DM medications Alpha-glucoside Inhibitors
Names - acarbose MOA: inhibits the intestinal brush boarder absorbtion of carbohydrates and therefore delays glucose SIDE Effects - **Flatulence** and dirrhea CI - cirrhosis adminster with meals: but not very effective
32
T2DM Medications SGLT2 inhibitors
Names - Canagliflozin - Dapagliflozin - Empagliflozin MOA: work to reduce glucose reabsorbtion at the lvel of the proximal tubules so that more glucose is excreted into the urine SIde Effect - **weight loss** - **anti-hypertensive properties** - UTI risk - dehydration and hypotention risk CI - Cannot be used in severe renal impairment ( GFR < 20) - watch in teh elderly **really good CVD protective effects, HTN lowering and renal protective, HF protective and CKD patients!!!**
33
how do Incretin Based Medication in T2DM work
DPP4 And GLP-1 agonists GLP-1 agonists: work like GLPs in the body to work on glucose dependent pathways in the body DPP4: stop the breakdown of GLP-1 therefore increasing their amount within the body the GLP-1agonist action within the body - stops glucagon secretion in the setting of hyperglycemia: therefore restoring the original function and signally of glucoagon to only happen when there is low glucose - theys timulate glucose dependent insulin secertion: therefore only secreting insulin wehn there is elevated levels of glusoe and low levels of insulin - they delay gastric emptying: leading to feelings of fullness and therefore weight loss - cardioprotective - triggers to the brain the "fullness feeling"
34
T2DM Medication DPP4 blockers
Names - sitagliptin - linagliptin - saxagliptin - alogliptin MOA: work to reduce the degradation of GLP-1 therefore increasing their activity within the body SIde Effects - weight neutral - no risk of hypoglycemia - oral meds!! a pluse **risk of medullary thyroid cancer and pancreatitc cancer** CI - pancreatitis - watch in CKD pts. **very well tolerated and liked because oral!
35
DM2TM Medication GLP-1 Agonists
GLP-1 Names - semaglutide (ozempic) - exenatide - liraglutide - albiglutide - duglutide MOA: work as GLP-1 to stimulate insulin production which is glucose dependent AND resistant to DPP4 degradation SIde Effects - **weight loss!** most effective with least side effects - no risk of hypoglycemia - can be used in CKD!! - GI: nausea, vomiting and diarrhea risk (with the daily or shorter acating, more thatn weekly) injections smaller risk of meduallary thryoid and pancreatic cancer - but still a risk CI pancreatitis relative CI: a bad GFR: < 29 or CKD/4-5 what to consider **ASCVD protective and CKD protective!!!**
36
oral agent of a GLP-1 Agonist name
semaglutide: Rybelsus - the weekly enjectable of ozempic now in an oral form with simialr effiacy but maybe slighly less weight loss
37
what is the combo GIP/GLP-1 agonist detail about teh drug
Tirzepatide (Mounjaro) - most potenet weight loss benefits and highest A1c reduction (2.1-2.4%) - injectable med but expensive
38
Additional DM medications - Colesevelam - Bromocriptine - Pramlintide
**Colesevelam** - a bile acid sequesterant whih decreases glucose in the serum (and LDL) - never replacing the need for a statin, but helpful for LDL and glucose lowering ability - Side Effects: constipation, nausea, dyspepsia, increased triglycerides **Bromocriptine** - dopamine agonist with additional cardiovacular protective effects - oral medication; limited by # of pilss and A1c reduction **Pramlintide** - given to patients taking pradial insulin, at each meal with similar effects as a GLP-1 agonist - utalizes the hormone amylin (T1DM and T2DM) - injectable; rarely used
39
guidelines of insulin thearpy in DM pts. Type 1 Type 2 | side effects of all insulin
T1DM: **insulin: basal is an absloute must in T1DM thearpy**: they focus on giving basal insulin then bolous (prandial) insulin following meal consumption T2DM: after trial of meds, and worsening progression of disease, these pt. may become insulin dependent as well generally, begin by giving basal insulin first before adding on bolous insulin (prandial) **Side Effects** - hypoglycemia - weight gain (promoting storage) - lipohypertrophy (if the location of injection is not rotated) insulin is giving va injection, pen, syrinage etc.
40
The long acting insulins: called Basal Insulin - names - how long they last - which is okay in pregnancy
ALL BASAL INSULIN HAS NO PEAK!!!! BECAUSE ITS BASAL **Detemir (Levemir)** - an 18-21 hour insulin : dosed 2x daily -**approved in pregnancy: M = mom** **Glargine (Lantus)** - 24 hour insulin: dosed 1x daily **toujeo** - 24 hour insulin like lantus Key: dose the 24hour insulin at bedtime; that way the basal has a chance to work and you can, as provider, adjust dosing overnight as needed
41
what is the 1 ultra-long acting insulin
**Degludec (Tresiba)** - a 42 hour insulin - can be used as basal thearpy
42
Intermediate acting insulin - when is it given - names
**NPH (humulin, novolin)** - a basal acting insulin: but given twice daily (10-18 hour insulin) - however less biologically simialr to normal insulin - **safe in pregnancy** - cost effective option but less used
43
Rapid Acting Insulin (prandial/bolus insulin) - Humalog, Novalog, Apidra - onset - who can be used in pregnancy
**Humalog, Novalog, Apidra** = short-acting 3-5 hour insulin with similar pharmacology - onset within 15 minutes: last a few hours - dosed with each meal (TID) - used as the sliding scale insulin in the hospital **humalog and novalog are safe in pregnancy**
44
Rapid Acting Insulin (prandial/bolus insulin) - Normal Insulin - onset - pros and cons
**Normal Insulin: Humilin R and Novolin R** - regular insulin: last 4-8 hours - not as physiologic as rapid acting insulin (takes a while to work) - **cost effective**
45
when is pre-mixed insulin used - what is it - names
**pre-mixed insulin can ONLY be used in the T2DM population, NEVER EVER type 1** - a mixture of rapid acting/short acting insulin together First # = the % of the dose is the NPH insulin (intermediate form) Second # = the % of the dose that is short acting (humalog, novolog, reg. insulin) **novolin, humalin LIN = mixed with regular insulin** which we dont love to use - Novolin 70/30, Humulin 70/30 - 10-18 hour insulin - dosed with breakfast and dinner - **down side is there is no lunchtime coverage: no dose midday** Humalog 75/25, Novolog 70/30, Humalog 50/50 - first # = longer actin NPH - second # is rapid humalog, novolog, - 10-18 hour - dose at breakfast and dinner, so again no lunchtime coverage
46
Concentrated Insulin - names - when is it used - pearls
concentrated insulin : those requiring higher dose of insulin; aka **insulin resistance pts.** Regular Insulin U500 - regular insulin at **5x the concentration** so 1 unit = 5 units of other insulin - dosed twice or 3x a day **avalible lantus U300 = 3x the concentration of normal lantus for daily dosing**
47
what is the goal of DM treatment A1c of what level
MOST pt. have a goal A1c level of 6.5-7% however, older pts. with more comorbidities we may be okay having their A1c more stable at a higher number ADA guidelines: 7% goal, with some popualtions (young healthy and controlled) can have goal of 6.5% **pts. with severe hypoglycemia, limited life, renal disease, vascular complications we are oka with 7-8% goal of the A1c**
48
Blood Sugar Goals for DM pts.
before meals: fasting BS **80-130** after meals: **< 180** measured 2 hours after
49
general plan of DM management for DM2
#1: lifestyle & adjustmenets non-pharm Pharm #1: if no contraindications, metformin use #2: a GLP-1 agonist or SGLT2 (becuase of the great cardioprotective effects) - if A1c > 1.5-2% above goal at dx. = can consider dual thearpy at start When to Start Insulin - the pt. is not at goal with meds, has lots of contra-indications - start with basal insulin first before adding on prandial **sometimes, you can give too much basal insulin when trying to get pt. to goal; at that point may have to lower basal and add prandial at meals or at largest meal spike**
50
General Plan of Treatment for T1DM
**insulin dependent thearpy** - MUST ALWAYS BE ON BASAL THEARPY !!! (even if NPO) **NEVER pre mixed insulin** given a basal + bolus example: lantus + humalog TID, levemir BID, Novolog TID
51
Insulin Regimen in T2DM pts.
starting these, in addition to the metformin and GLP or SGLT2 theyre on .... - after d/c the glinides/sulfonaureas 1. start with basal insulin, low dose & titrate up as needed ADA: **0.1 to 0.2 units/kg for TDD OR 10 units per day** 2. when adding bolous insulin, necessary to adjust the spikes which are occuring post-meals - ADA: starting bolous, add after largest meal spike (dinner) or after each meal - **start 4 units of bolous insulin TOTAL per day** - **or can calculate: 0.1 to 2 units/kg TDD** so 50% of the TDD = basal then 50% of the TDD: bolous (split into three for each meal)
52
Carb Counting and DM
**ESSENTAIL practice for T1Dm** I:C ratio = insulin to carbohydrate ratio - every 10 g of carbs = 1 unit of insulin if the ratio is 1:10 - example: 1:10 ratio = for every 10 carbs, 1 unit given. pt. eating 50 carbs in the meal. 50/10 = 5 so they get 5 units if dont know, take 500 and divide the TDD from it so 500/TDD = the 1: whatever ratio